• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过盐水提取人脑组织制备的凝血活酶中纤维蛋白形成的抑制剂。

An inhibitor of fibrin formation in thromboplastins prepared by saline extraction of human brain.

作者信息

Duncan B M, Lloyd J V

出版信息

Br J Haematol. 1978 Apr;38(4):551-60. doi: 10.1111/j.1365-2141.1978.tb01080.x.

DOI:10.1111/j.1365-2141.1978.tb01080.x
PMID:646953
Abstract

Human brain is a common source of thromboplastin for the prothrombin time, where the end point is the conversion of fibrinogen to fibrin. Experiments showed that human brain also contains a proteolipid which inhibits the conversion of fibrinogen to fibrin. The proteolipid is removed when brain tissue is washed with acetone, but remains as a contaminant when brain is extracted with saline. For this reason prothrombin times on the same plasma are longer when saline extracts, rather than acetone dried preparations, are the source of thromboplastin. The proteolipid explains why the prothrombin time becomes shorter when saline extracts are diluted to standardize their activity against the British comparative thromboplastin.

摘要

人脑是凝血酶原时间检测中凝血活酶的常见来源,该检测的终点是纤维蛋白原转化为纤维蛋白。实验表明,人脑还含有一种蛋白脂质,它会抑制纤维蛋白原转化为纤维蛋白。用丙酮洗涤脑组织时,该蛋白脂质会被去除,但用盐水提取脑组织时,它会作为污染物残留下来。因此,当以盐水提取物而非丙酮干燥制剂作为凝血活酶来源时,同一血浆的凝血酶原时间会更长。这种蛋白脂质解释了为什么将盐水提取物稀释以使其活性与英国比较凝血活酶标准化时,凝血酶原时间会变短。

相似文献

1
An inhibitor of fibrin formation in thromboplastins prepared by saline extraction of human brain.通过盐水提取人脑组织制备的凝血活酶中纤维蛋白形成的抑制剂。
Br J Haematol. 1978 Apr;38(4):551-60. doi: 10.1111/j.1365-2141.1978.tb01080.x.
2
A human brain thromboplastin standard for distribution in South Africa.一种供在南非分发的人源脑凝血活酶标准品。
S Afr Med J. 1976 Nov 20;50(50):1989-92.
3
[Comparative analysis of 2 thromboplastins].[两种凝血活酶的比较分析]
Minerva Med. 1998 Sep;89(9):303-8.
4
[Prothrombin time and its standardization].[凝血酶原时间及其标准化]
Rinsho Byori. 2002 Aug;50(8):779-85.
5
Prothrombin time standardization: report of the expert panel on oral anticoagulant control. The International Committee on Thrombosis and Haemostasis, The International Committee for Standardization in Hematology.凝血酶原时间标准化:口服抗凝剂控制专家小组报告。国际血栓与止血委员会,国际血液学标准化委员会。
Thromb Haemost. 1979 Dec 21;42(4):1073-114.
6
Thrombomodulin activity in commercial thromboplastin preparations.商用凝血活酶制剂中的血栓调节蛋白活性。
Thromb Res. 1986 Aug 1;43(3):265-74. doi: 10.1016/0049-3848(86)90146-5.
7
Investigation and standardization of prothrombin times in chickens.鸡凝血酶原时间的研究与标准化
Poult Sci. 1975 Jul;54(4):969-80. doi: 10.3382/ps.0540969.
8
The "therapeutic range" of the one-stage prothrombin time in the control of anticoagulant therapy: the effect of different thromboplastin preparations.一期凝血酶原时间在抗凝治疗控制中的“治疗范围”:不同凝血活酶制剂的影响
Can Med Assoc J. 1971 Nov 20;105(10):1041-3 passim.
9
Prothrombin time in the monitoring of oral anticoagulant: a comparison of results using different thromboplastins.
Ann Biol Clin (Paris). 1990;48(8):547-50.
10
Thromboplastic activity of acetone-dehydrated chicken brain powder extracts after repeated extraction and dilution.反复提取和稀释后丙酮脱水鸡脑粉提取物的促凝血活性。
Poult Sci. 1972 Mar;51(2):402-7. doi: 10.3382/ps.0510402.